Advanced search
Publication Cover
Leukemia & Lymphoma Volume 55, 2014 - Issue 7
Submit an article Journal homepage
3,934
Views
37
CrossRef citations to date
0
Altmetric
Research Article

Target-directed development and preclinical characterization of the proposed biosimilar rituximab GP2013

Antonio da SilvaSandoz Biopharmaceuticals/Hexal AG, Holzkirchen, GermanyCorrespondence[email protected]
,
Ulrich KronthalerSandoz Biopharmaceuticals/Hexal AG, Holzkirchen, Germany
,
Vera KoppenburgSandoz Biopharmaceuticals/Hexal AG, Holzkirchen, Germany
,
Martin FinkNovartis Institutes for Biomedical Research/Novartis Pharma AG, Basel, Switzerland
,
Ines MeyerSandoz Biopharmaceuticals/Hexal AG, Holzkirchen, Germany
,
Anastassia PapandrikopoulouSandoz Biopharmaceuticals/Hexal AG, Holzkirchen, Germany
,
Matthias HofmannNovartis Institutes for Biomedical Research/Novartis Pharma AG, Basel, Switzerland
,
Thomas StanglerSandoz Biopharmaceuticals/Sandoz GmbH, Kundl, Austria
&
Jan VisserSandoz Biopharmaceuticals/Hexal AG, Holzkirchen, Germany
 show all
Pages 1609-1617 | Received 03 Jul 2013, Accepted 06 Sep 2013, Published online: 24 Jan 2014

Reprints and Permissions

Taylor & Francis does not sell reprints or permissions for this article. Please refer to the 'Licensing' tab on the article menu bar for information on the reuse conditions associated with this license type.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.